Package 63459-104-50

Brand: truxima

Generic: rituximab-abbs
NDC Package

Package Facts

Identity

Package NDC 63459-104-50
Digits Only 6345910450
Product NDC 63459-104
Product ID 63459-104_de5d8106-44b8-4510-9129-f6a163c5231e
Description

1 VIAL, SINGLE-USE in 1 CARTON (63459-104-50) / 50 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2020-05-04
Brand truxima
Generic rituximab-abbs
Sample Package No

Linked Drug Pages (1)

Truxima ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "de5d8106-44b8-4510-9129-f6a163c5231e", "openfda": {"nui": ["N0000175078", "N0000175657"], "unii": ["4F4X42SYQ6"], "rxcui": ["2105826", "2105831", "2105834", "2105835"], "spl_set_id": ["9af3ddc7-4217-417a-ac89-8704edc5bc44"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Cephalon, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (63459-104-50)  / 50 mL in 1 VIAL, SINGLE-USE", "package_ndc": "63459-104-50", "marketing_start_date": "20200504"}], "brand_name": "Truxima", "product_id": "63459-104_de5d8106-44b8-4510-9129-f6a163c5231e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "63459-104", "generic_name": "rituximab-abbs", "labeler_name": "Cephalon, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Truxima", "active_ingredients": [{"name": "RITUXIMAB", "strength": "10 mg/mL"}], "application_number": "BLA761088", "marketing_category": "BLA", "marketing_start_date": "20200504", "listing_expiration_date": "20261231"}